Glutathione S-transferase π1 promotes tumorigenicity in HCT116 human colon cancer cells

被引:62
作者
Dang, DT
Chen, F
Kohli, M
Rago, C
Cummins, JM
Dang, LH
机构
[1] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[4] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
10.1158/0008-5472.CAN-05-1930
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
GSTP1 is a member of the glutathione S-transferase enzyme superfamily, which catalyzes the conjugation of electrophiles with glutathione in the process of detoxification. GSTP1 is widely overexpressed in colorectal cancer, from aberrant crypt foci to advanced carcinomas. Increased expression of GSTP1 is associated with multidrug resistance and a worse clinical prognosis. However, GSTP1-null mice have an increased risk of tumor formation. Thus, the biological function of GSTP1 in colorectal cancer biology remains speculative. In an effort to gain further insights into the role of GSTP1 in tumorigenesis, we disrupted the GSTP1 gene in HCT116 human colorectal cancer cells using targeted homologous recombination. We find that loss of GSTP1 resulted in impaired clonogenic survival and proliferation. Specifically, under growth-limiting conditions, (a) GSTP1 protected HCT116 cells from oxidative stress and associated apoptosis and (b) promoted mitogen-activated protein kinase-extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase-mediated G(1)-S cell cycle progression. In vivo, GSTP1 was critical for engraftment and growth of HCT116 tumor xenografts. These studies directly show that GSTP1 promotes clonogenic survival and proliferation in HCT116 human colon cancer cells.
引用
收藏
页码:9485 / 9494
页数:10
相关论文
共 69 条
[1]   Regulation of JNK signaling by GSTp [J].
Adler, V ;
Yin, ZM ;
Fuchs, SY ;
Benezra, M ;
Rosario, L ;
Tew, KD ;
Pincus, MR ;
Sardana, M ;
Henderson, CJ ;
Wolf, CR ;
Davis, RJ ;
Ronai, Z .
EMBO JOURNAL, 1999, 18 (05) :1321-1334
[2]  
Ali-Osman F, 1997, CLIN CANCER RES, V3, P2253
[3]  
Ban N, 1996, CANCER RES, V56, P3577
[4]   Oncogenic resistance to growth-limiting conditions [J].
Blagosklonny, MV .
NATURE REVIEWS CANCER, 2002, 2 (03) :221-225
[5]  
BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173
[6]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[7]   Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation [J].
Chan, TA ;
Wang, ZH ;
Dang, LH ;
Vogelstein, B ;
Kinzler, KW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8265-8270
[8]   GLUTATHIONE S-TRANSFERASES IN NORMAL AND MALIGNANT HUMAN COLON TISSUE [J].
CLAPPER, ML ;
HOFFMAN, SJ ;
TEW, KD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (03) :209-216
[9]   CONTRIBUTION OF PATIENT HISTORY TO THE GLUTATHIONE-S-TRANSFERASE ACTIVITY OF HUMAN LUNG, BREAST AND COLON TISSUE [J].
CLAPPER, ML ;
HOFFMAN, SJ ;
CARP, N ;
WATTS, P ;
SEESTALLER, LM ;
WEESE, JL ;
TEW, KD .
CARCINOGENESIS, 1991, 12 (10) :1957-1961
[10]  
Conzen SD, 1995, ONCOGENE, V11, P2295